{
  "ticker": "CRL",
  "last_updated": "2025-04-19T10:04:54.704574",
  "retention_years": 3,
  "count": 730,
  "transactions": [
    {
      "id": 272670,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2025-02-25",
      "transaction_shares": "430",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "54628"
    },
    {
      "id": 315102,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2025-02-25",
      "transaction_shares": "430",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "54628"
    },
    {
      "id": 361512,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2025-02-25",
      "transaction_shares": "430",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "54628"
    },
    {
      "id": 272636,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2025-02-20",
      "transaction_shares": "6075",
      "transaction_price": "165.01",
      "transaction_type": "P",
      "shares_after_transaction": "183639"
    },
    {
      "id": 272651,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2025-02-20",
      "transaction_shares": "1514",
      "transaction_price": "164.63",
      "transaction_type": "P",
      "shares_after_transaction": "55058"
    },
    {
      "id": 272665,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2025-02-20",
      "transaction_shares": "4400",
      "transaction_price": "162.50",
      "transaction_type": "S",
      "shares_after_transaction": "20013"
    },
    {
      "id": 315068,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2025-02-20",
      "transaction_shares": "6075",
      "transaction_price": "165.01",
      "transaction_type": "P",
      "shares_after_transaction": "183639"
    },
    {
      "id": 315083,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2025-02-20",
      "transaction_shares": "1514",
      "transaction_price": "164.63",
      "transaction_type": "P",
      "shares_after_transaction": "55058"
    },
    {
      "id": 315097,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2025-02-20",
      "transaction_shares": "4400",
      "transaction_price": "162.50",
      "transaction_type": "S",
      "shares_after_transaction": "20013"
    },
    {
      "id": 361478,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2025-02-20",
      "transaction_shares": "6075",
      "transaction_price": "165.01",
      "transaction_type": "P",
      "shares_after_transaction": "183639"
    },
    {
      "id": 361493,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2025-02-20",
      "transaction_shares": "1514",
      "transaction_price": "164.63",
      "transaction_type": "P",
      "shares_after_transaction": "55058"
    },
    {
      "id": 361507,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2025-02-20",
      "transaction_shares": "4400",
      "transaction_price": "162.50",
      "transaction_type": "S",
      "shares_after_transaction": "20013"
    },
    {
      "id": 272622,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2025-01-31",
      "transaction_shares": "4057",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "54569"
    },
    {
      "id": 272623,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2025-01-31",
      "transaction_shares": "1758",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9470"
    },
    {
      "id": 272631,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2025-01-31",
      "transaction_shares": "2738",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25259"
    },
    {
      "id": 272637,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2025-01-31",
      "transaction_shares": "811",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9137"
    },
    {
      "id": 272658,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2025-01-31",
      "transaction_shares": "19608",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "204391"
    },
    {
      "id": 272660,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2025-01-31",
      "transaction_shares": "2468",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "17297"
    },
    {
      "id": 272685,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2025-01-31",
      "transaction_shares": "2704",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12464"
    },
    {
      "id": 315054,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2025-01-31",
      "transaction_shares": "4057",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "54569"
    },
    {
      "id": 315055,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2025-01-31",
      "transaction_shares": "1758",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9470"
    },
    {
      "id": 315063,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2025-01-31",
      "transaction_shares": "2738",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25259"
    },
    {
      "id": 315069,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2025-01-31",
      "transaction_shares": "811",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9137"
    },
    {
      "id": 315090,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2025-01-31",
      "transaction_shares": "19608",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "204391"
    },
    {
      "id": 315092,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2025-01-31",
      "transaction_shares": "2468",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "17297"
    },
    {
      "id": 315117,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2025-01-31",
      "transaction_shares": "2704",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12464"
    },
    {
      "id": 361464,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2025-01-31",
      "transaction_shares": "4057",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "54569"
    },
    {
      "id": 361465,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2025-01-31",
      "transaction_shares": "1758",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9470"
    },
    {
      "id": 361473,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2025-01-31",
      "transaction_shares": "2738",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25259"
    },
    {
      "id": 361479,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2025-01-31",
      "transaction_shares": "811",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9137"
    },
    {
      "id": 361500,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2025-01-31",
      "transaction_shares": "19608",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "204391"
    },
    {
      "id": 361502,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2025-01-31",
      "transaction_shares": "2468",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "17297"
    },
    {
      "id": 361527,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2025-01-31",
      "transaction_shares": "2704",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12464"
    },
    {
      "id": 171495,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-11-08",
      "transaction_shares": "4500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "184783"
    },
    {
      "id": 202656,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-11-08",
      "transaction_shares": "4500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "184783"
    },
    {
      "id": 236144,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-11-08",
      "transaction_shares": "4500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "184783"
    },
    {
      "id": 272675,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-11-08",
      "transaction_shares": "4500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "184783"
    },
    {
      "id": 315107,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-11-08",
      "transaction_shares": "4500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "184783"
    },
    {
      "id": 361517,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-11-08",
      "transaction_shares": "4500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "184783"
    },
    {
      "id": 171487,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-11-07",
      "transaction_shares": "470",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "23337"
    },
    {
      "id": 202648,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-11-07",
      "transaction_shares": "470",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "23337"
    },
    {
      "id": 236136,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-11-07",
      "transaction_shares": "470",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "23337"
    },
    {
      "id": 272666,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-11-07",
      "transaction_shares": "470",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "23337"
    },
    {
      "id": 315098,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-11-07",
      "transaction_shares": "470",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "23337"
    },
    {
      "id": 361508,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-11-07",
      "transaction_shares": "470",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "23337"
    },
    {
      "id": 171484,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-06",
      "transaction_shares": "4540",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "19007"
    },
    {
      "id": 202645,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-06",
      "transaction_shares": "4540",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "19007"
    },
    {
      "id": 236133,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-06",
      "transaction_shares": "4540",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "19007"
    },
    {
      "id": 272662,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-06",
      "transaction_shares": "4540",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "19007"
    },
    {
      "id": 315094,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-06",
      "transaction_shares": "4540",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "19007"
    },
    {
      "id": 361504,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-06",
      "transaction_shares": "4540",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "19007"
    },
    {
      "id": 91658,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-12",
      "transaction_shares": "2500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "185751"
    },
    {
      "id": 116313,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-12",
      "transaction_shares": "2500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "185751"
    },
    {
      "id": 142857,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-12",
      "transaction_shares": "2500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "185751"
    },
    {
      "id": 171462,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-12",
      "transaction_shares": "2500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "185751"
    },
    {
      "id": 202623,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-12",
      "transaction_shares": "2500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "185751"
    },
    {
      "id": 236111,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-12",
      "transaction_shares": "2500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "185751"
    },
    {
      "id": 272635,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-12",
      "transaction_shares": "2500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "185751"
    },
    {
      "id": 315067,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-12",
      "transaction_shares": "2500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "185751"
    },
    {
      "id": 361477,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-12",
      "transaction_shares": "2500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "185751"
    },
    {
      "id": 91693,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-08-08",
      "transaction_shares": "1780",
      "transaction_price": "199.36",
      "transaction_type": "S",
      "shares_after_transaction": "22521"
    },
    {
      "id": 116348,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-08-08",
      "transaction_shares": "1780",
      "transaction_price": "199.36",
      "transaction_type": "S",
      "shares_after_transaction": "22521"
    },
    {
      "id": 142892,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-08-08",
      "transaction_shares": "1780",
      "transaction_price": "199.36",
      "transaction_type": "S",
      "shares_after_transaction": "22521"
    },
    {
      "id": 171500,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-08-08",
      "transaction_shares": "1780",
      "transaction_price": "199.36",
      "transaction_type": "S",
      "shares_after_transaction": "22521"
    },
    {
      "id": 202661,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-08-08",
      "transaction_shares": "1780",
      "transaction_price": "199.36",
      "transaction_type": "S",
      "shares_after_transaction": "22521"
    },
    {
      "id": 236149,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-08-08",
      "transaction_shares": "1780",
      "transaction_price": "199.36",
      "transaction_type": "S",
      "shares_after_transaction": "22521"
    },
    {
      "id": 272680,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-08-08",
      "transaction_shares": "1780",
      "transaction_price": "199.36",
      "transaction_type": "S",
      "shares_after_transaction": "22521"
    },
    {
      "id": 315112,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-08-08",
      "transaction_shares": "1780",
      "transaction_price": "199.36",
      "transaction_type": "S",
      "shares_after_transaction": "22521"
    },
    {
      "id": 361522,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-08-08",
      "transaction_shares": "1780",
      "transaction_price": "199.36",
      "transaction_type": "S",
      "shares_after_transaction": "22521"
    },
    {
      "id": 91648,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-01",
      "transaction_shares": "25000",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "188251"
    },
    {
      "id": 116303,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-01",
      "transaction_shares": "25000",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "188251"
    },
    {
      "id": 142847,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-01",
      "transaction_shares": "25000",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "188251"
    },
    {
      "id": 171452,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-01",
      "transaction_shares": "25000",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "188251"
    },
    {
      "id": 202613,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-01",
      "transaction_shares": "25000",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "188251"
    },
    {
      "id": 236101,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-01",
      "transaction_shares": "25000",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "188251"
    },
    {
      "id": 272624,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-01",
      "transaction_shares": "25000",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "188251"
    },
    {
      "id": 315056,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-01",
      "transaction_shares": "25000",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "188251"
    },
    {
      "id": 361466,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-01",
      "transaction_shares": "25000",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "188251"
    },
    {
      "id": 48985,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-06-03",
      "transaction_shares": "311",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "24301"
    },
    {
      "id": 69251,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-06-03",
      "transaction_shares": "311",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "24301"
    },
    {
      "id": 91686,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-06-03",
      "transaction_shares": "311",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "24301"
    },
    {
      "id": 116341,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-06-03",
      "transaction_shares": "311",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "24301"
    },
    {
      "id": 142885,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-06-03",
      "transaction_shares": "311",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "24301"
    },
    {
      "id": 171492,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-06-03",
      "transaction_shares": "311",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "24301"
    },
    {
      "id": 202653,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-06-03",
      "transaction_shares": "311",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "24301"
    },
    {
      "id": 236141,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-06-03",
      "transaction_shares": "311",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "24301"
    },
    {
      "id": 272672,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-06-03",
      "transaction_shares": "311",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "24301"
    },
    {
      "id": 315104,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-06-03",
      "transaction_shares": "311",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "24301"
    },
    {
      "id": 361514,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-06-03",
      "transaction_shares": "311",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "24301"
    },
    {
      "id": 48949,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "648",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8326"
    },
    {
      "id": 48972,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1967",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14829"
    },
    {
      "id": 48975,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2111",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24612"
    },
    {
      "id": 48978,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2159",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9760"
    },
    {
      "id": 48981,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "3838",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "50512"
    },
    {
      "id": 48994,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1727",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8406"
    },
    {
      "id": 69215,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "648",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8326"
    },
    {
      "id": 69238,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1967",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14829"
    },
    {
      "id": 69241,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2111",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24612"
    },
    {
      "id": 69244,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2159",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9760"
    },
    {
      "id": 69247,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "3838",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "50512"
    },
    {
      "id": 69260,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1727",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8406"
    },
    {
      "id": 91649,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "648",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8326"
    },
    {
      "id": 91673,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1967",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14829"
    },
    {
      "id": 91676,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2111",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24612"
    },
    {
      "id": 91679,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2159",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9760"
    },
    {
      "id": 91682,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "3838",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "50512"
    },
    {
      "id": 91696,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1727",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8406"
    },
    {
      "id": 116304,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "648",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8326"
    },
    {
      "id": 116328,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1967",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14829"
    },
    {
      "id": 116331,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2111",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24612"
    },
    {
      "id": 116334,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2159",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9760"
    },
    {
      "id": 116337,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "3838",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "50512"
    },
    {
      "id": 116351,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1727",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8406"
    },
    {
      "id": 142848,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "648",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8326"
    },
    {
      "id": 142872,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1967",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14829"
    },
    {
      "id": 142875,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2111",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24612"
    },
    {
      "id": 142878,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2159",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9760"
    },
    {
      "id": 142881,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "3838",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "50512"
    },
    {
      "id": 142895,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1727",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8406"
    },
    {
      "id": 171453,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "648",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8326"
    },
    {
      "id": 171477,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1967",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14829"
    },
    {
      "id": 171480,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2111",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24612"
    },
    {
      "id": 171483,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2159",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9760"
    },
    {
      "id": 171488,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "3838",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "50512"
    },
    {
      "id": 171503,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1727",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8406"
    },
    {
      "id": 202614,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "648",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8326"
    },
    {
      "id": 202638,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1967",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14829"
    },
    {
      "id": 202641,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2111",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24612"
    },
    {
      "id": 202644,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2159",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9760"
    },
    {
      "id": 202649,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "3838",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "50512"
    },
    {
      "id": 202664,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1727",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8406"
    },
    {
      "id": 236102,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "648",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8326"
    },
    {
      "id": 236126,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1967",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14829"
    },
    {
      "id": 236129,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2111",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24612"
    },
    {
      "id": 236132,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2159",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9760"
    },
    {
      "id": 236137,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "3838",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "50512"
    },
    {
      "id": 236152,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1727",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8406"
    },
    {
      "id": 272625,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "648",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8326"
    },
    {
      "id": 272653,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1967",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14829"
    },
    {
      "id": 272656,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2111",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24612"
    },
    {
      "id": 272661,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2159",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9760"
    },
    {
      "id": 272667,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "3838",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "50512"
    },
    {
      "id": 272683,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1727",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8406"
    },
    {
      "id": 315057,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "648",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8326"
    },
    {
      "id": 315085,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1967",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14829"
    },
    {
      "id": 315088,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2111",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24612"
    },
    {
      "id": 315093,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2159",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9760"
    },
    {
      "id": 315099,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "3838",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "50512"
    },
    {
      "id": 315115,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1727",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8406"
    },
    {
      "id": 361467,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "648",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8326"
    },
    {
      "id": 361495,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1967",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14829"
    },
    {
      "id": 361498,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2111",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24612"
    },
    {
      "id": 361503,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "2159",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9760"
    },
    {
      "id": 361509,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-31",
      "transaction_shares": "3838",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "50512"
    },
    {
      "id": 361525,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-31",
      "transaction_shares": "1727",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8406"
    },
    {
      "id": 48947,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "190",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "12947"
    },
    {
      "id": 48950,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-29",
      "transaction_shares": "110",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "6679"
    },
    {
      "id": 48951,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "216",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "46674"
    },
    {
      "id": 48953,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-29",
      "transaction_shares": "223",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "22501"
    },
    {
      "id": 48954,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "179",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "3433"
    },
    {
      "id": 48962,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "36",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "7678"
    },
    {
      "id": 48988,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "1274",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "223044"
    },
    {
      "id": 69213,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "190",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "12947"
    },
    {
      "id": 69216,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-29",
      "transaction_shares": "110",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "6679"
    },
    {
      "id": 69217,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "216",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "46674"
    },
    {
      "id": 69219,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-29",
      "transaction_shares": "223",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "22501"
    },
    {
      "id": 69220,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "179",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "3433"
    },
    {
      "id": 69228,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "36",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "7678"
    },
    {
      "id": 69254,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "1274",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "223044"
    },
    {
      "id": 91646,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "190",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "12947"
    },
    {
      "id": 91650,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-29",
      "transaction_shares": "110",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "6679"
    },
    {
      "id": 91651,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "216",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "46674"
    },
    {
      "id": 91653,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-29",
      "transaction_shares": "223",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "22501"
    },
    {
      "id": 91654,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "179",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "3433"
    },
    {
      "id": 91663,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "36",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "7678"
    },
    {
      "id": 91689,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "1274",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "223044"
    },
    {
      "id": 116301,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "190",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "12947"
    },
    {
      "id": 116305,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-29",
      "transaction_shares": "110",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "6679"
    },
    {
      "id": 116306,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "216",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "46674"
    },
    {
      "id": 116308,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-29",
      "transaction_shares": "223",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "22501"
    },
    {
      "id": 116309,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "179",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "3433"
    },
    {
      "id": 116318,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "36",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "7678"
    },
    {
      "id": 116344,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "1274",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "223044"
    },
    {
      "id": 142845,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "190",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "12947"
    },
    {
      "id": 142849,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-29",
      "transaction_shares": "110",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "6679"
    },
    {
      "id": 142850,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "216",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "46674"
    },
    {
      "id": 142852,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-29",
      "transaction_shares": "223",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "22501"
    },
    {
      "id": 142853,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "179",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "3433"
    },
    {
      "id": 142862,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "36",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "7678"
    },
    {
      "id": 142888,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "1274",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "223044"
    },
    {
      "id": 171450,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "190",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "12947"
    },
    {
      "id": 171454,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-29",
      "transaction_shares": "110",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "6679"
    },
    {
      "id": 171455,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "216",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "46674"
    },
    {
      "id": 171457,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-29",
      "transaction_shares": "223",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "22501"
    },
    {
      "id": 171458,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "179",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "3433"
    },
    {
      "id": 171467,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "36",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "7678"
    },
    {
      "id": 171496,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "1274",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "223044"
    },
    {
      "id": 202611,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "190",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "12947"
    },
    {
      "id": 202615,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-29",
      "transaction_shares": "110",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "6679"
    },
    {
      "id": 202616,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "216",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "46674"
    },
    {
      "id": 202618,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-29",
      "transaction_shares": "223",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "22501"
    },
    {
      "id": 202619,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "179",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "3433"
    },
    {
      "id": 202628,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "36",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "7678"
    },
    {
      "id": 202657,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "1274",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "223044"
    },
    {
      "id": 236099,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "190",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "12947"
    },
    {
      "id": 236103,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-29",
      "transaction_shares": "110",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "6679"
    },
    {
      "id": 236104,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "216",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "46674"
    },
    {
      "id": 236106,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-29",
      "transaction_shares": "223",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "22501"
    },
    {
      "id": 236107,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "179",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "3433"
    },
    {
      "id": 236116,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "36",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "7678"
    },
    {
      "id": 236145,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "1274",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "223044"
    },
    {
      "id": 272620,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "190",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "12947"
    },
    {
      "id": 272626,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-29",
      "transaction_shares": "110",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "6679"
    },
    {
      "id": 272627,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "216",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "46674"
    },
    {
      "id": 272629,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-29",
      "transaction_shares": "223",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "22501"
    },
    {
      "id": 272630,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "179",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "3433"
    },
    {
      "id": 272642,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "36",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "7678"
    },
    {
      "id": 272676,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "1274",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "223044"
    },
    {
      "id": 315052,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "190",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "12947"
    },
    {
      "id": 315058,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-29",
      "transaction_shares": "110",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "6679"
    },
    {
      "id": 315059,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "216",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "46674"
    },
    {
      "id": 315061,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-29",
      "transaction_shares": "223",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "22501"
    },
    {
      "id": 315062,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "179",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "3433"
    },
    {
      "id": 315074,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "36",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "7678"
    },
    {
      "id": 315108,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "1274",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "223044"
    },
    {
      "id": 361462,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "190",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "12947"
    },
    {
      "id": 361468,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-29",
      "transaction_shares": "110",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "6679"
    },
    {
      "id": 361469,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "216",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "46674"
    },
    {
      "id": 361471,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-29",
      "transaction_shares": "223",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "22501"
    },
    {
      "id": 361472,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "179",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "3433"
    },
    {
      "id": 361484,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-29",
      "transaction_shares": "36",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "7678"
    },
    {
      "id": 361518,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "1274",
      "transaction_price": "214.51",
      "transaction_type": "F",
      "shares_after_transaction": "223044"
    },
    {
      "id": 48945,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "50",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7775"
    },
    {
      "id": 48957,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "180",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "13336"
    },
    {
      "id": 48958,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-26",
      "transaction_shares": "168",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "6939"
    },
    {
      "id": 48959,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "177",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "3821"
    },
    {
      "id": 48973,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-26",
      "transaction_shares": "243",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "23033"
    },
    {
      "id": 48980,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "376",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "47264"
    },
    {
      "id": 48995,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "212",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7795"
    },
    {
      "id": 69211,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "50",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7775"
    },
    {
      "id": 69223,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "180",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "13336"
    },
    {
      "id": 69224,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-26",
      "transaction_shares": "168",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "6939"
    },
    {
      "id": 69225,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "177",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "3821"
    },
    {
      "id": 69239,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-26",
      "transaction_shares": "243",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "23033"
    },
    {
      "id": 69246,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "376",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "47264"
    },
    {
      "id": 69261,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "212",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7795"
    },
    {
      "id": 91644,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "50",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7775"
    },
    {
      "id": 91657,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "180",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "13336"
    },
    {
      "id": 91659,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-26",
      "transaction_shares": "168",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "6939"
    },
    {
      "id": 91660,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "177",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "3821"
    },
    {
      "id": 91674,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-26",
      "transaction_shares": "243",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "23033"
    },
    {
      "id": 91681,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "376",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "47264"
    },
    {
      "id": 91697,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "212",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7795"
    },
    {
      "id": 116299,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "50",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7775"
    },
    {
      "id": 116312,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "180",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "13336"
    },
    {
      "id": 116314,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-26",
      "transaction_shares": "168",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "6939"
    },
    {
      "id": 116315,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "177",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "3821"
    },
    {
      "id": 116329,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-26",
      "transaction_shares": "243",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "23033"
    },
    {
      "id": 116336,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "376",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "47264"
    },
    {
      "id": 116352,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "212",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7795"
    },
    {
      "id": 142843,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "50",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7775"
    },
    {
      "id": 142856,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "180",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "13336"
    },
    {
      "id": 142858,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-26",
      "transaction_shares": "168",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "6939"
    },
    {
      "id": 142859,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "177",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "3821"
    },
    {
      "id": 142873,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-26",
      "transaction_shares": "243",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "23033"
    },
    {
      "id": 142880,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "376",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "47264"
    },
    {
      "id": 142896,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "212",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7795"
    },
    {
      "id": 171448,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "50",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7775"
    },
    {
      "id": 171461,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "180",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "13336"
    },
    {
      "id": 171463,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-26",
      "transaction_shares": "168",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "6939"
    },
    {
      "id": 171464,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "177",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "3821"
    },
    {
      "id": 171478,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-26",
      "transaction_shares": "243",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "23033"
    },
    {
      "id": 171486,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "376",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "47264"
    },
    {
      "id": 171504,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "212",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7795"
    },
    {
      "id": 202609,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "50",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7775"
    },
    {
      "id": 202622,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "180",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "13336"
    },
    {
      "id": 202624,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-26",
      "transaction_shares": "168",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "6939"
    },
    {
      "id": 202625,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "177",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "3821"
    },
    {
      "id": 202639,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-26",
      "transaction_shares": "243",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "23033"
    },
    {
      "id": 202647,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "376",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "47264"
    },
    {
      "id": 202665,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "212",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7795"
    },
    {
      "id": 236097,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "50",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7775"
    },
    {
      "id": 236110,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "180",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "13336"
    },
    {
      "id": 236112,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-26",
      "transaction_shares": "168",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "6939"
    },
    {
      "id": 236113,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "177",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "3821"
    },
    {
      "id": 236127,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-26",
      "transaction_shares": "243",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "23033"
    },
    {
      "id": 236135,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "376",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "47264"
    },
    {
      "id": 236153,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "212",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7795"
    },
    {
      "id": 272618,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "50",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7775"
    },
    {
      "id": 272634,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "180",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "13336"
    },
    {
      "id": 272638,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-26",
      "transaction_shares": "168",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "6939"
    },
    {
      "id": 272639,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "177",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "3821"
    },
    {
      "id": 272654,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-26",
      "transaction_shares": "243",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "23033"
    },
    {
      "id": 272664,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "376",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "47264"
    },
    {
      "id": 272684,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "212",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7795"
    },
    {
      "id": 315050,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "50",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7775"
    },
    {
      "id": 315066,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "180",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "13336"
    },
    {
      "id": 315070,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-26",
      "transaction_shares": "168",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "6939"
    },
    {
      "id": 315071,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "177",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "3821"
    },
    {
      "id": 315086,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-26",
      "transaction_shares": "243",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "23033"
    },
    {
      "id": 315096,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "376",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "47264"
    },
    {
      "id": 315116,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "212",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7795"
    },
    {
      "id": 361460,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "50",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7775"
    },
    {
      "id": 361476,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-05-26",
      "transaction_shares": "180",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "13336"
    },
    {
      "id": 361480,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-05-26",
      "transaction_shares": "168",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "6939"
    },
    {
      "id": 361481,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "177",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "3821"
    },
    {
      "id": 361496,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-26",
      "transaction_shares": "243",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "23033"
    },
    {
      "id": 361506,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "376",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "47264"
    },
    {
      "id": 361526,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-26",
      "transaction_shares": "212",
      "transaction_price": "217.21",
      "transaction_type": "F",
      "shares_after_transaction": "7795"
    },
    {
      "id": 31255,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-15",
      "transaction_shares": "123",
      "transaction_price": "234.72",
      "transaction_type": "S",
      "shares_after_transaction": "6064"
    },
    {
      "id": 48974,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-15",
      "transaction_shares": "123",
      "transaction_price": "234.72",
      "transaction_type": "S",
      "shares_after_transaction": "6064"
    },
    {
      "id": 69240,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-15",
      "transaction_shares": "123",
      "transaction_price": "234.72",
      "transaction_type": "S",
      "shares_after_transaction": "6064"
    },
    {
      "id": 91675,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-15",
      "transaction_shares": "123",
      "transaction_price": "234.72",
      "transaction_type": "S",
      "shares_after_transaction": "6064"
    },
    {
      "id": 116330,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-15",
      "transaction_shares": "123",
      "transaction_price": "234.72",
      "transaction_type": "S",
      "shares_after_transaction": "6064"
    },
    {
      "id": 142874,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-15",
      "transaction_shares": "123",
      "transaction_price": "234.72",
      "transaction_type": "S",
      "shares_after_transaction": "6064"
    },
    {
      "id": 171479,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-15",
      "transaction_shares": "123",
      "transaction_price": "234.72",
      "transaction_type": "S",
      "shares_after_transaction": "6064"
    },
    {
      "id": 202640,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-15",
      "transaction_shares": "123",
      "transaction_price": "234.72",
      "transaction_type": "S",
      "shares_after_transaction": "6064"
    },
    {
      "id": 236128,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-15",
      "transaction_shares": "123",
      "transaction_price": "234.72",
      "transaction_type": "S",
      "shares_after_transaction": "6064"
    },
    {
      "id": 272655,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-15",
      "transaction_shares": "123",
      "transaction_price": "234.72",
      "transaction_type": "S",
      "shares_after_transaction": "6064"
    },
    {
      "id": 315087,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-15",
      "transaction_shares": "123",
      "transaction_price": "234.72",
      "transaction_type": "S",
      "shares_after_transaction": "6064"
    },
    {
      "id": 361497,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-15",
      "transaction_shares": "123",
      "transaction_price": "234.72",
      "transaction_type": "S",
      "shares_after_transaction": "6064"
    },
    {
      "id": 31250,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "1467"
    },
    {
      "id": 31253,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "7894"
    },
    {
      "id": 31254,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "729"
    },
    {
      "id": 31256,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3965"
    },
    {
      "id": 31261,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3018"
    },
    {
      "id": 31262,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "32408"
    },
    {
      "id": 31263,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "6187"
    },
    {
      "id": 31264,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "23087"
    },
    {
      "id": 31265,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "12159"
    },
    {
      "id": 31267,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3043"
    },
    {
      "id": 48967,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "1467"
    },
    {
      "id": 48970,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "7894"
    },
    {
      "id": 48971,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "729"
    },
    {
      "id": 48976,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3965"
    },
    {
      "id": 48984,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3018"
    },
    {
      "id": 48986,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "32408"
    },
    {
      "id": 48987,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "6187"
    },
    {
      "id": 48989,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "23087"
    },
    {
      "id": 48990,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "12159"
    },
    {
      "id": 48992,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3043"
    },
    {
      "id": 69233,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "1467"
    },
    {
      "id": 69236,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "7894"
    },
    {
      "id": 69237,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "729"
    },
    {
      "id": 69242,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3965"
    },
    {
      "id": 69250,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3018"
    },
    {
      "id": 69252,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "32408"
    },
    {
      "id": 69253,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "6187"
    },
    {
      "id": 69255,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "23087"
    },
    {
      "id": 69256,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "12159"
    },
    {
      "id": 69258,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3043"
    },
    {
      "id": 91668,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "1467"
    },
    {
      "id": 91671,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "7894"
    },
    {
      "id": 91672,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "729"
    },
    {
      "id": 91677,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3965"
    },
    {
      "id": 91685,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3018"
    },
    {
      "id": 91687,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "32408"
    },
    {
      "id": 91688,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "6187"
    },
    {
      "id": 91690,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "23087"
    },
    {
      "id": 91691,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "12159"
    },
    {
      "id": 91694,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3043"
    },
    {
      "id": 116323,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "1467"
    },
    {
      "id": 116326,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "7894"
    },
    {
      "id": 116327,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "729"
    },
    {
      "id": 116332,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3965"
    },
    {
      "id": 116340,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3018"
    },
    {
      "id": 116342,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "32408"
    },
    {
      "id": 116343,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "6187"
    },
    {
      "id": 116345,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "23087"
    },
    {
      "id": 116346,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "12159"
    },
    {
      "id": 116349,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3043"
    },
    {
      "id": 142867,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "1467"
    },
    {
      "id": 142870,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "7894"
    },
    {
      "id": 142871,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "729"
    },
    {
      "id": 142876,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3965"
    },
    {
      "id": 142884,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3018"
    },
    {
      "id": 142886,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "32408"
    },
    {
      "id": 142887,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "6187"
    },
    {
      "id": 142889,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "23087"
    },
    {
      "id": 142890,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "12159"
    },
    {
      "id": 142893,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3043"
    },
    {
      "id": 171472,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "1467"
    },
    {
      "id": 171475,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "7894"
    },
    {
      "id": 171476,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "729"
    },
    {
      "id": 171481,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3965"
    },
    {
      "id": 171491,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3018"
    },
    {
      "id": 171493,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "32408"
    },
    {
      "id": 171494,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "6187"
    },
    {
      "id": 171497,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "23087"
    },
    {
      "id": 171498,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "12159"
    },
    {
      "id": 171501,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3043"
    },
    {
      "id": 202633,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "1467"
    },
    {
      "id": 202636,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "7894"
    },
    {
      "id": 202637,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "729"
    },
    {
      "id": 202642,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3965"
    },
    {
      "id": 202652,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3018"
    },
    {
      "id": 202654,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "32408"
    },
    {
      "id": 202655,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "6187"
    },
    {
      "id": 202658,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "23087"
    },
    {
      "id": 202659,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "12159"
    },
    {
      "id": 202662,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3043"
    },
    {
      "id": 236121,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "1467"
    },
    {
      "id": 236124,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "7894"
    },
    {
      "id": 236125,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "729"
    },
    {
      "id": 236130,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3965"
    },
    {
      "id": 236140,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3018"
    },
    {
      "id": 236142,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "32408"
    },
    {
      "id": 236143,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "6187"
    },
    {
      "id": 236146,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "23087"
    },
    {
      "id": 236147,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "12159"
    },
    {
      "id": 236150,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3043"
    },
    {
      "id": 272647,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "1467"
    },
    {
      "id": 272650,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "7894"
    },
    {
      "id": 272652,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "729"
    },
    {
      "id": 272657,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3965"
    },
    {
      "id": 272671,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3018"
    },
    {
      "id": 272673,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "32408"
    },
    {
      "id": 272674,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "6187"
    },
    {
      "id": 272677,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "23087"
    },
    {
      "id": 272678,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "12159"
    },
    {
      "id": 272681,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3043"
    },
    {
      "id": 315079,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "1467"
    },
    {
      "id": 315082,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "7894"
    },
    {
      "id": 315084,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "729"
    },
    {
      "id": 315089,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3965"
    },
    {
      "id": 315103,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3018"
    },
    {
      "id": 315105,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "32408"
    },
    {
      "id": 315106,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "6187"
    },
    {
      "id": 315109,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "23087"
    },
    {
      "id": 315110,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "12159"
    },
    {
      "id": 315113,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3043"
    },
    {
      "id": 361489,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "1467"
    },
    {
      "id": 361492,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "7894"
    },
    {
      "id": 361494,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "729"
    },
    {
      "id": 361499,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3965"
    },
    {
      "id": 361513,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3018"
    },
    {
      "id": 361515,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "32408"
    },
    {
      "id": 361516,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "6187"
    },
    {
      "id": 361519,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "23087"
    },
    {
      "id": 361520,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "12159"
    },
    {
      "id": 361523,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-13",
      "transaction_shares": "559",
      "transaction_price": "228.41",
      "transaction_type": "A",
      "shares_after_transaction": "3043"
    },
    {
      "id": 31257,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-10",
      "transaction_shares": "1304",
      "transaction_price": "226.97",
      "transaction_type": "S",
      "shares_after_transaction": "23276"
    },
    {
      "id": 48977,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-10",
      "transaction_shares": "1304",
      "transaction_price": "226.97",
      "transaction_type": "S",
      "shares_after_transaction": "23276"
    },
    {
      "id": 69243,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-10",
      "transaction_shares": "1304",
      "transaction_price": "226.97",
      "transaction_type": "S",
      "shares_after_transaction": "23276"
    },
    {
      "id": 91678,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-10",
      "transaction_shares": "1304",
      "transaction_price": "226.97",
      "transaction_type": "S",
      "shares_after_transaction": "23276"
    },
    {
      "id": 116333,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-10",
      "transaction_shares": "1304",
      "transaction_price": "226.97",
      "transaction_type": "S",
      "shares_after_transaction": "23276"
    },
    {
      "id": 142877,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-10",
      "transaction_shares": "1304",
      "transaction_price": "226.97",
      "transaction_type": "S",
      "shares_after_transaction": "23276"
    },
    {
      "id": 171482,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-10",
      "transaction_shares": "1304",
      "transaction_price": "226.97",
      "transaction_type": "S",
      "shares_after_transaction": "23276"
    },
    {
      "id": 202643,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-10",
      "transaction_shares": "1304",
      "transaction_price": "226.97",
      "transaction_type": "S",
      "shares_after_transaction": "23276"
    },
    {
      "id": 236131,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-10",
      "transaction_shares": "1304",
      "transaction_price": "226.97",
      "transaction_type": "S",
      "shares_after_transaction": "23276"
    },
    {
      "id": 272659,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-10",
      "transaction_shares": "1304",
      "transaction_price": "226.97",
      "transaction_type": "S",
      "shares_after_transaction": "23276"
    },
    {
      "id": 315091,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-10",
      "transaction_shares": "1304",
      "transaction_price": "226.97",
      "transaction_type": "S",
      "shares_after_transaction": "23276"
    },
    {
      "id": 361501,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-05-10",
      "transaction_shares": "1304",
      "transaction_price": "226.97",
      "transaction_type": "S",
      "shares_after_transaction": "23276"
    },
    {
      "id": 31260,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "893",
      "transaction_price": "232.69",
      "transaction_type": "F",
      "shares_after_transaction": "8007"
    },
    {
      "id": 48983,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "893",
      "transaction_price": "232.69",
      "transaction_type": "F",
      "shares_after_transaction": "8007"
    },
    {
      "id": 69249,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "893",
      "transaction_price": "232.69",
      "transaction_type": "F",
      "shares_after_transaction": "8007"
    },
    {
      "id": 91684,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "893",
      "transaction_price": "232.69",
      "transaction_type": "F",
      "shares_after_transaction": "8007"
    },
    {
      "id": 116339,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "893",
      "transaction_price": "232.69",
      "transaction_type": "F",
      "shares_after_transaction": "8007"
    },
    {
      "id": 142883,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "893",
      "transaction_price": "232.69",
      "transaction_type": "F",
      "shares_after_transaction": "8007"
    },
    {
      "id": 171490,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "893",
      "transaction_price": "232.69",
      "transaction_type": "F",
      "shares_after_transaction": "8007"
    },
    {
      "id": 202651,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "893",
      "transaction_price": "232.69",
      "transaction_type": "F",
      "shares_after_transaction": "8007"
    },
    {
      "id": 236139,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "893",
      "transaction_price": "232.69",
      "transaction_type": "F",
      "shares_after_transaction": "8007"
    },
    {
      "id": 272669,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "893",
      "transaction_price": "232.69",
      "transaction_type": "F",
      "shares_after_transaction": "8007"
    },
    {
      "id": 315101,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "893",
      "transaction_price": "232.69",
      "transaction_type": "F",
      "shares_after_transaction": "8007"
    },
    {
      "id": 361511,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "893",
      "transaction_price": "232.69",
      "transaction_type": "F",
      "shares_after_transaction": "8007"
    },
    {
      "id": 6603,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 17533,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 31243,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 48955,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 69221,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 91655,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 116310,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 142854,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 171459,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 202620,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 236108,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 272632,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 315064,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 361474,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 6609,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 17539,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 31249,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 48965,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 69231,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 91666,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 116321,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 142865,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 171470,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 202631,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 236119,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 272645,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 315077,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 361487,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 6610,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 6612,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 17540,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 17542,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 31251,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 31258,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 48968,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 48979,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 69234,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 69245,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 91669,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 91680,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 116324,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 116335,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 142868,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 142879,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 171473,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 171485,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 202634,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 202646,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 236122,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 236134,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 272648,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 272663,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 315080,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 315095,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 361490,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 361505,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 6615,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 17545,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 31268,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 48993,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 69259,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 91695,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 116350,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 142894,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 171502,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 202663,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 236151,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 272682,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 315114,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 361524,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 663,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 6600,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 17530,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 31240,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 48946,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 69212,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 91645,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 116300,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 142844,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 171449,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 202610,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 236098,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 272619,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 315051,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 361461,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 666,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 667,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 672,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 6604,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 6605,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 6613,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 17534,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 17535,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 17543,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 31244,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 31245,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 31259,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 48956,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 48960,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 48982,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 69222,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 69226,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 69248,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 91656,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 91661,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 91683,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 116311,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 116316,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 116338,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 142855,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 142860,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 142882,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 171460,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 171465,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 171489,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 202621,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 202626,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 202650,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 236109,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 236114,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 236138,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 272633,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 272640,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 272668,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 315065,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 315072,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 315100,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 361475,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 361482,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 361510,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 668,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 6606,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 17536,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 31246,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 48961,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 69227,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 91662,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 116317,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 142861,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 171466,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 202627,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 236115,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 272641,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 315073,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 361483,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 661,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 662,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 664,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 665,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 669,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 670,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 671,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 673,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 6598,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 6599,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 6601,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 6602,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 6607,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 6608,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 6611,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 6614,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 17528,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 17529,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 17531,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 17532,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 17537,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 17538,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 17541,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 17544,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 31238,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 31239,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 31241,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 31242,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 31247,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 31248,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 31252,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 31266,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 48943,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 48944,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 48948,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 48952,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 48963,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 48964,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 48969,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 48991,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 69209,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 69210,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 69214,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 69218,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 69229,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 69230,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 69235,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 69257,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 91642,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 91643,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 91647,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 91652,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 91664,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 91665,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 91670,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 91692,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 116297,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 116298,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 116302,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 116307,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 116319,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 116320,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 116325,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 116347,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 142841,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 142842,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 142846,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 142851,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 142863,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 142864,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 142869,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 142891,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 171446,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 171447,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 171451,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 171456,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 171468,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 171469,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 171474,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 171499,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 202607,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 202608,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 202612,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 202617,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 202629,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 202630,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 202635,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 202660,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 236095,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 236096,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 236100,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 236105,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 236117,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 236118,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 236123,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 236148,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 272616,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 272617,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 272621,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 272628,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 272643,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 272644,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 272649,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 272679,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 315048,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 315049,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 315053,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 315060,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 315075,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 315076,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 315081,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 315111,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 361458,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 361459,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 361463,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 361470,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 361485,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 361486,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 361491,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 361521,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    }
  ]
}